Taysha Gene Therapies (TSHA) Construction in Progress (2021 - 2022)
Taysha Gene Therapies (TSHA) posted Construction in Progress of $59.0 million for Q3 2022, up 1803.23% sequentially from $3.1 million in Q2 2022, and up 160662.94% YoY from N/an in Q3 2021.
Taysha Gene Therapies (TSHA) Construction in Progress (2021 - 2022) Analysis & Trends
Taysha Gene Therapies has reported Construction in Progress for 2 years, with the latest figure at $59.0 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 152.67 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Taysha Gene Therapies | 1.94 Bn | 1.94 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 59.00 Mn |
| Jun 30, 2022 | 3.10 Mn |
| Mar 31, 2022 | 50.40 Mn |
| Sep 30, 2021 | 36,700.00 |
| Jun 30, 2021 | 30.30 Mn |